About The Medical Condition EN1639A
Find the definition of the medical term EN1639A. EN1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN1639A
| EN1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Accesses, Facility ‐ Designs for approaching areas inside or outside…
- Veronal ‐ A long-acting barbiturate that depresses most metabolic processes…
- Puppet Children ‐ A syndrome characterized by multiple abnormalities, MENTAL RETARDATION,…
- Juvenile Absence Epilepsy ‐ A childhood seizure disorder characterized by rhythmic electrical…
- Flight Reactions ‐ Innate response elicited by sensory stimuli associated with a…
- Test, Speech Discrimination ‐ Tests of the ability to hear and understand speech as determined…
- Antisense DNA ‐ DNA that is complementary to the sense strand. (The sense strand…
- Denture, Partial, Temporary ‐ A partial denture intended for short-term use in a temporary…
- Alpha-Agonists, Adrenergic ‐ Drugs that selectively bind to and activate alpha adrenergic…
- Risk Appraisal, Health ‐ The measurement of the health status for a given population using…